Literature DB >> 20570703

Divergent M- and O-superfamily peptides from venom of fish-hunting Conus parius.

Elsie C Jimenez1, Baldomero M Olivera.   

Abstract

Six novel peptides from the piscivorous cone snail, Conus parius were purified by reverse-phase HPLC fractionation of crude venom. With the use of matrix-assisted laser desorption ionization mass spectrometry and standard Edman sequencing methods, the peptides were characterized. Two peptides were identified as members of the m-2 and m-4 branches of the M-superfamily and were designated as pr3a and pr3b, while four peptides were identified as members of the O-superfamily and were designated as pr6a, pr6b, pr6c and pr6d. Peptide pr3a differs from the majority of the M-superfamily peptides in the presence of two prolines, which are not modified to 4-trans-hydroxyproline. In peptide pr3b, five amino acids out of the 16 non-cysteine residues are identical with those of mu-GIIIA and mu-PIIIA, suggesting that pr3b may be a divergent mu-conotoxin. Peptide pr6a is notable because of its extreme hydrophobicity. Peptide pr6c has three prolines that are unhydroxylated. Peptides pr6b and pr6d differ from the previously characterized O-superfamily peptides in the presence of an extended N-terminus consisting of six amino acids. Peptides pr3a, pr3b, pr6a and pr6b were demonstrated to be biologically active when injected intraperitoneally in fish. The identification and characterization of these peptides in venom of a fish-hunting species establish the divergence of gene products and their patterns of post-translational modification within superfamilies in a single Conus species. Copyright 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20570703      PMCID: PMC2922443          DOI: 10.1016/j.peptides.2010.05.020

Source DB:  PubMed          Journal:  Peptides        ISSN: 0196-9781            Impact factor:   3.750


  20 in total

1.  A novel conus peptide ligand for K+ channels.

Authors:  Michael Ferber; Annett Sporning; Gunnar Jeserich; Richard DeLaCruz; Maren Watkins; Baldomero M Olivera; Heinrich Terlau
Journal:  J Biol Chem       Date:  2002-10-23       Impact factor: 5.157

Review 2.  Conus peptides: biodiversity-based discovery and exogenomics.

Authors:  Baldomero M Olivera
Journal:  J Biol Chem       Date:  2006-08-11       Impact factor: 5.157

3.  Conus geographus toxins that discriminate between neuronal and muscle sodium channels.

Authors:  L J Cruz; W R Gray; B M Olivera; R D Zeikus; L Kerr; D Yoshikami; E Moczydlowski
Journal:  J Biol Chem       Date:  1985-08-05       Impact factor: 5.157

4.  kappa-Conotoxin PVIIA is a peptide inhibiting the shaker K+ channel.

Authors:  K J Shon; M Stocker; H Terlau; W Stühmer; R Jacobsen; C Walker; M Grilley; M Watkins; D R Hillyard; W R Gray; B M Olivera
Journal:  J Biol Chem       Date:  1998-01-02       Impact factor: 5.157

5.  Definition of the M-conotoxin superfamily: characterization of novel peptides from molluscivorous Conus venoms.

Authors:  Gloria P Corpuz; Richard B Jacobsen; Elsie C Jimenez; Maren Watkins; Craig Walker; Clark Colledge; James E Garrett; Owen McDougal; Wenqin Li; William R Gray; David R Hillyard; Jean Rivier; J Michael McIntosh; Lourdes J Cruz; Baldomero M Olivera
Journal:  Biochemistry       Date:  2005-06-07       Impact factor: 3.162

6.  A toxin from the venom of the marine snail Conus geographus which acts on the vertebrate central nervous system.

Authors:  C Clark; B M Olivera; L J Cruz
Journal:  Toxicon       Date:  1981       Impact factor: 3.033

7.  E.E. Just Lecture, 1996. Conus venom peptides, receptor and ion channel targets, and drug design: 50 million years of neuropharmacology.

Authors:  B M Olivera
Journal:  Mol Biol Cell       Date:  1997-11       Impact factor: 4.138

8.  Purification and sequence of a presynaptic peptide toxin from Conus geographus venom.

Authors:  B M Olivera; J M McIntosh; L J Cruz; F A Luque; W R Gray
Journal:  Biochemistry       Date:  1984-10-23       Impact factor: 3.162

Review 9.  Conus venoms: a rich source of novel ion channel-targeted peptides.

Authors:  Heinrich Terlau; Baldomero M Olivera
Journal:  Physiol Rev       Date:  2004-01       Impact factor: 37.312

10.  Role of hydroxyprolines in the in vitro oxidative folding and biological activity of conotoxins.

Authors:  Estuardo Lopez-Vera; Aleksandra Walewska; Jack J Skalicky; Baldomero M Olivera; Grzegorz Bulaj
Journal:  Biochemistry       Date:  2008-01-12       Impact factor: 3.162

View more
  5 in total

1.  Conus coronatus and Conus frigidus Venom: A New Source of Conopeptides with Analgesic Activity.

Authors:  Halimeh Rajabi; Hossein Zolgharnein; Mohammad Taghi Ronagh; Jamshid Amiri Moghaddam; Max Crüsemann
Journal:  Avicenna J Med Biotechnol       Date:  2020 Jul-Sep

2.  Mass spectrometric identification and denovo sequencing of novel conotoxins from vermivorous cone snail (Conus inscriptus), and preliminary screening of its venom for biological activities in vitro and in vivo.

Authors:  Ruchi P Jain; Benjamin Franklin Jayaseelan; Carlton Ranjith Wilson Alphonse; Ahmed Hossam Mahmoud; Osama B Mohammed; Bandar Mohsen Ahmed Almunqedhi; Rajesh Rajaian Pushpabai
Journal:  Saudi J Biol Sci       Date:  2020-12-24       Impact factor: 4.219

3.  ConoServer: updated content, knowledge, and discovery tools in the conopeptide database.

Authors:  Quentin Kaas; Rilei Yu; Ai-Hua Jin; Sébastien Dutertre; David J Craik
Journal:  Nucleic Acids Res       Date:  2011-11-03       Impact factor: 16.971

4.  Novel Conopeptides of Largely Unexplored Indo Pacific Conus sp.

Authors:  Eline K M Lebbe; Maarten G K Ghequire; Steve Peigneur; Bea G Mille; Prabha Devi; Samuthirapandian Ravichandran; Etienne Waelkens; Lisette D'Souza; René De Mot; Jan Tytgat
Journal:  Mar Drugs       Date:  2016-10-27       Impact factor: 5.118

Review 5.  Discovery Methodology of Novel Conotoxins from Conus Species.

Authors:  Ying Fu; Cheng Li; Shuai Dong; Yong Wu; Dongting Zhangsun; Sulan Luo
Journal:  Mar Drugs       Date:  2018-10-30       Impact factor: 5.118

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.